NDC 70518-3965-01 - Doxazosin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-3965
- Requested NDC
- 70518-3965-01
- Package NDCs from labels
- 70518-3965-0, 70518-3965-1, 70518-3965-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-06-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Doxazosin - REMEDYREPACK INC. | REMEDYREPACK INC. | 2026-06-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-3965-0 | Doxazosin | 30 in 1 BLISTER PACK | TABLET | 30 | 4 | |
| 70518-3965-1 | Doxazosin | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-3965 | DOXAZOSIN TABLET [REMEDYREPACK INC.] | 3 | Current NDC, 2 package rows | 20240503_ec06f008-37a1-4757-a3ee-0b4720912bc4.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Doxazosin | DOXAZOSIN | Accord Healthcare Inc. | 2830533c-ccdf-4401-b19c-763eeb1bc0a7 | 2024-08-15 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | NuCare Pharmaceuticals, Inc. | 40e47e75-6a47-323b-e054-00144ff8d46c | 2024-08-14 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | NuCare Pharmaceuticals, Inc. | 505d3c4c-5506-72cc-e054-00144ff88e88 | 2024-07-09 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 7991373e-8a62-47f9-b4fb-90573485af4e | 2024-07-04 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Rising Pharma Holdings, Inc. | 508b908e-8d80-422e-8ec0-2081185f4c95 | 2024-06-19 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | A-S Medication Solutions | 4034fb6d-f55d-4df0-b500-d6a413591f6e | 2024-06-12 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | A-S Medication Solutions | 9f67fa58-f623-4145-9e2c-98feee7ca45f | 2024-06-10 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | A-S Medication Solutions | 46b01b1d-c48a-4c36-bf3c-bba98066166c | 2024-06-10 | Warnings, Adverse reactions | ANDA208719 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | NuCare Pharmaceuticals,Inc. | 64a243e6-7056-115d-e053-2a91aa0a510f | 2024-06-06 | Warnings, Adverse reactions | 197625 86P6PQK0MU |
| Calamine | FERRIC OXIDE RED | NuCare Pharmaceuticals,Inc. | 66e98554-e158-a519-e053-2a91aa0a6783 | 2024-06-06 | Warnings, Adverse reactions | 1K09F3G675 |
| Doxazosin | DOXAZOSIN | NuCare Pharmaceuticals,Inc. | 64a19cb1-79fc-8b0b-e053-2a91aa0aaa94 | 2024-06-06 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Proficient Rx LP | 1d8ff659-8129-4dca-9e8f-13b97240d1e1 | 2024-06-01 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Aphena Pharma Solutions - Tennessee, LLC | 187bc51b-7a3a-5910-e063-6294a90aa888 | 2024-05-15 | Warnings, Adverse reactions | ANDA208719 197628 86P6PQK0MU |
| Enviroclenz | BERBERIS VULGARIS, CARDUUS MARIANUS, CHELIDONIUM MAJUS, GLYCYRRHIZA GLABRA, LAPPA MAJOR, RHAMNUS FRANGULA, STILLINGIA SYLVATICA, TARAXACUM OFFICINALE, TRIFOLIUM PRATENSE, GERMANIUM SESQUIOXIDE, PHYTOLACCA DECANDRA, ACETONE, AMMONIUM MURIATICUM, BENZINUM, PROPYLENE GLYCOL, SODIUM LAURYL SULFATE, SODIUM TRIPOLYPHOSPHATE, TEREBINTHINA, METHANOL, CHLORINUM, IRIDIUM METALLICUM, LYCOPODIUM CLAVATUM, NITRICUM ACIDUM, NUX VOMICA, PHOSPHORICUM ACIDUM | Deseret Biologicals, Inc. | 92816bbe-96d6-45fc-9929-d3e6df394a33 | 2024-05-02 | Warnings | 368GB5141J |
| Doxazosin | DOXAZOSIN | Bryant Ranch Prepack | 6fbb9ca2-e8ca-45c7-a178-b4c8dd7a9a1f | 2024-04-29 | Warnings, Adverse reactions | ANDA208719 197626 86P6PQK0MU |
| Envirotox | TRITICUM AESTIVUM, BERBERIS VULGARIS, LAPPA MAJOR, RHAMNUS PURSHIANA, SENNS (CASSIA ANGUSTIFOLIA), PHYTOLACCA DECANDRA, GLYCYRRHIZA GLABRA, STILLINGIA SYLVATICA, TRIFOLIUM PRATENSE, XANTHOXYLUM FRAXINEUM, ACETONUM ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, BELLADONNA, LYCOPODIUM CLAVATUM, NITRICUM ACIDUM, NUX VOMICA, PHOSPHORICUM ACIDUM, BELLADONNA, LYCOPODIUM CLAVATUM, NITRICUM ACIDUM, NUX VOMICA, PHOSPHORICUM ACIDUM. | BioActive Nutritional, Inc. | 2b5cfdba-cf4d-4eb0-8c60-20eac6922663 | 2024-03-26 | Warnings | 368GB5141J |
| Doxazosin mesylate | DOXAZOSIN MESYLATE | Mylan Pharmaceuticals Inc. | 2e524986-7903-416f-b2b8-d27295103e75 | 2024-03-11 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN MESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 0d9df8e9-f823-4ff8-a5fe-0309dd132b04 | 2024-02-06 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin Mesylate | DOXAZOSIN MESYLATE | Unichem Pharmaceuticals (USA), Inc. | 44bfe5d7-a56a-46f1-8ef3-ad386ab35f0f | 2024-01-23 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Cardura | DOXAZOSIN | Viatris Specialty LLC | 5e1f5e49-2da1-43ab-9795-228a8bcc5a82 | 2023-10-15 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.